Abstract
Psychological distress is a public health issue as it contributes to the development of human diseases including neuropathologies. Parkinson’s disease (PD), a chronic, progressive neurodegenerative disorder, is caused by multiple factors including aging, mitochondrial dysfunction, and/or stressors. In PD, a substantial loss of substantia nigra (SN) neurons leads to rigid tremors, bradykinesia, and chronic fatigue. Several studies have reported that the hypothalamic-pituitary-adrenal (HPA) axis is altered in PD patients, leading to an increase level of cortisol which contributes to neurodegeneration and oxidative stress. We hypothesized that chronic psychological distress induces PD-like symptoms and promotes neurodegeneration in wild-type (WT) rats and exacerbates PD pathology in PINK1 knockout (KO) rats, a well-validated animal model of PD. We measured the bioenergetics profile (oxidative phosphorylation and glycolysis) in the brain by employing an XF24e Seahorse Extracellular Flux Analyzer in young rats subjected to predator-induced psychological distress. In addition, we analyzed anxiety-like behavior, motor function, expression of antioxidant enzymes, mitochondrial content, and neurotrophic factors brain-derived neurotrophic factor (BDNF) in the brain. Overall, we observed that psychological distress diminished up to 50% of mitochondrial respiration and glycolysis in the prefrontal cortex (PFC) derived from both WT and PINK1-KO rats. Mechanistically, the level of antioxidant proteins, mitochondrial content, and BDNF was significantly altered. Finally, psychological distress robustly induced anxiety and Parkinsonian symptoms in WT rats and accelerated certain symptoms of PD in PINK1-KO rats. For the first time, our collective data suggest that psychological distress can phenocopy several aspects of PD neuropathology, disrupt brain energy production, as well as induce ataxia-like behavior.
Similar content being viewed by others
Data Availability
All data of this study are available from the corresponding authors.
References
Sulzer D, Surmeier DJ (2014) Neuronal vulnerability, pathogenesis and Parkinson’s disease. Mov Disord 28:41–50. https://doi.org/10.1002/mds.25095.Neuronal
Willard AM, Bouchard RS, Gittis AH (2015) Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice. Neuroscience 301:254–267. https://doi.org/10.1016/j.physbeh.2017.03.040
Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921. https://doi.org/10.1212/wnl.54.10.1916
Narayanan NS, Rodnitzky RL, Uc E (2013) Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. Rev Neurosci 24:1–17. https://doi.org/10.1515/revneuro-2013-0004.Prefrontal
Herz DM, Siebner HR, Hulme OJ, Florin E, Christensen MS, Timmermann L (2014) Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson’ s disease. Neuroimage 90:15–23. https://doi.org/10.1016/j.neuroimage.2013.11.023
Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nature 3:1–21. https://doi.org/10.1038/nrdp.2017.13
Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A et al (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56:336–341. https://doi.org/10.1002/ana.20256
Das Banerjee T, Dagda RY, Dagda M, Chu CT, Rice M, Vazquez-Mayorga E, Dagda RK (2017) PINK1 regulates mitochondrial trafficking in dendrites of cortical neurons through mitochondrial PKA. J Neurochem 142:545–559. https://doi.org/10.1111/jnc.14083
Sekine S, Youle RJ (2018) PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol. BMC Biol 16:1–12. https://doi.org/10.1186/s12915-017-0470-7
Dodson MW, Guo M (2007) Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson’s disease. Curr Opin Neurobiol 17:331–337. https://doi.org/10.1016/j.conb.2007.04.010
Creed RB, Goldberg MS (2018) New developments in genetic rat models of Parkinson’s disease. Mov Disord 33:717–729. https://doi.org/10.1002/mds.27296
Dave KD, De Silva S, Sheth NP et al (2014) Phenotypic characterization of recessive gene knockout rat models of Parkinson’s disease. Neurobiol Dis 70:190–203. https://doi.org/10.1016/j.nbd.2014.06.009
Kyser TL, Dourson AJ, McGuire JL et al (2019) Characterization of motor and non-motor behavioral alterations in the Dj-1 (PARK7) knockout rat. J Mol Neurosci 1:298–311. https://doi.org/10.1007/s12031-019-01358-0
Grant LM, Kelm-Nelson CA, Hilby BL, Blue KV, Paul Rajamanickam ES, Pultorak JD, Fleming SM, Ciucci MR (2015) Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson’s disease. J Neurosci Res 93:1713–1727. https://doi.org/10.1002/jnr.23625
Marquis JM, Lettenberger SE, Kelm-Nelsona CA (2020) Early-onset Parkinsonian behaviors in female Pink1−/− rats. Behav Brain Res 377:1–15. https://doi.org/10.1016/j.bbr.2019.112175
Ren X, Hinchie A, Swomley A, Powell DK, Butterfield DA (2019) Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: relevance to Parkinson disease. Free Radic Biol Med 143:146–152. https://doi.org/10.1016/j.freeradbiomed.2019.08.008
Gemechu JM, Sharma A, Yu D, Xie Y, Merkel OM, Moszczynska A (2018) Characterization of dopaminergic system in the striatum of young adult Park2 −/− knockout rats. Sci Rep 8:1–19. https://doi.org/10.1038/s41598-017-18526-0
Stauch KL, Villeneuve LM, Purnell PR, Ottemann BM, Emanuel K, Fox HS (2016) Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration. Proteomics Clin Appl 10:1205–1217. https://doi.org/10.1002/prca.201600005
Ferris CF, Morrison TR, Iriah S, Malmberg S, Kulkarni P, Hartner JC, Trivedi M (2018) Evidence of neurobiological changes in the presymptomatic PINK1 knockout rat. J Park Dis 8:281–301. https://doi.org/10.3233/JPD-171273
Villeneuve LM, Purnell PR, Boska MD, Fox HS (2016) Early expression of Parkinson’s disease-related mitochondrial abnormalities in PINK1 knockout rats. Mol Neurobiol 53:171–186. https://doi.org/10.1007/s12035-014-8927-y
Creed RB, Menalled L, Casey B, Dave KD, Janssens HB, Veinbergs I, van der Hart M, Rassoulpour A et al (2019) Basal and evoked neurotransmitter levels in Parkin, DJ-1, PINK1 and LRRK2 knockout rat striatum. Neuroscience 409:169–179. https://doi.org/10.1016/j.neuroscience.2019.04.033
Zhi L, Qin Q, Muqeem T, Seifert EL, Liu W, Zheng S, Li C, Zhang H (2018) Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction. Neurobiol Aging 75:1–10. https://doi.org/10.1016/j.neurobiolaging.2018.10.025
Borgonovo J, Allende-Castro C, Laliena A et al (2017) Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson’s disease. Parkinsonism Relat Disord 35:17–24. https://doi.org/10.1016/j.parkreldis.2016.11.009
Wang Y, Liu H, Du X et al (2017) Association of low serum BDNF with depression in patients with Parkinson’s disease. Parkinsonism Relat Disord 41:73–78. https://doi.org/10.1016/j.parkreldis.2017.05.012.This
Scalzo P, Kummer A, Bretas TL et al (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’ s disease. J Neurol 257:540–545. https://doi.org/10.1007/s00415-009-5357-2
Smith AD, Castro SL, Zigmond MJ (2002) Stress-induced Parkinson’ s disease: a working hypothesis. Physiol Behav 77:527–531. https://doi.org/10.1016/S0031-9384(02)00939-3
Fontoura JL, Baptista C, Pedroso FDB et al (2017) Depression in Parkinson’s disease: the contribution from animal studies. Parkinsons Dis 2017:1–8. https://doi.org/10.1155/2017/9124160
Vargas-Caraveo A, Perez-Ishiwara DG, Martinez-Martinez A (2015) Chronic psychological distress as an inducer of microglial activation and leukocyte recruitment into the area postrema. Neuroimmunomodulation:1–11. https://doi.org/10.1159/000369350
McEwen BS, Nasca C, Gray JD (2016) Stress effects on neuronal structure: hippocampus , amygdala, and prefrontal cortex. Neuropsychopharmacology 41:3–23. https://doi.org/10.1038/npp.2015.171
Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB (2014) Stress exacerbates experimental Parkinson’s disease. Mol Psychiatry 19:638–640. https://doi.org/10.1038/mp.2013.108
Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S, Metz GA (2008) Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson’s disease. Eur J Neurosci 27:2133–2146. https://doi.org/10.1111/j.1460-9568.2008.06177.x
Sierra-Fonseca JA, Gosselink KL (2018) Tauopathy and neurodegeneration: a role for stress. Neurobiol Stress 9:105–112. https://doi.org/10.1016/j.ynstr.2018.08.009
Mejia-Carmona GE, Gosselink KL, Pérez-Ishiwara G, Martínez-Martínez A (2015) Oxidant/antioxidant effects of chronic exposure to predator odor in prefrontal cortex, amygdala, and hypothalamus. Mol Cell Biochem 406:121–129. https://doi.org/10.1007/s11010-015-2430-2
Grigoruţă M, Vargas-Caraveo A, Vázquez-Mayorga E et al (2018) Blood mononuclear cells as speculum of emotional stress analyzed by synchrotron infrared spectroscopy and a nootropic drug. Spectrochim Acta - A Mol Biomol Spectrosc 204:475–483. https://doi.org/10.1016/j.saa.2018.06.075
Mejia-Carmona GE, Gosselink KL, de la Rosa LA et al (2014) Evaluation of antioxidant enzymes in response to predator odor stress in prefrontal cortex and amygdala. Neurochem J 8:125–128. https://doi.org/10.1134/S181971241402007X
Höschl C, Hajek T (2001) Hippocampal damage mediated by corticosteroids — a neuropsychiatric research challenge. Eur Arch Psychiatry Clin Neurosci 251:81–88. https://doi.org/10.1007/bf03035134
Zhang B, Zhang Y, Wu W, Xu T, Yin Y, Zhang J, Huang D, Li W (2017) Chronic glucocorticoid exposure activates BK-NLRP1 signal involving in hippocampal neuron damage. J Neuroinflammation 14:1–13. https://doi.org/10.1186/s12974-017-0911-9
Herrero M-T, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson’s disease: role of glucocorticoids. Front Neuroanat 9:1–12. https://doi.org/10.3389/fnana.2015.00032
Kilkenny C, Browne WJ, Cuthill IC et al (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. PLoS Biol 8:1–5. https://doi.org/e1000412. https://doi.org/10.1371/journal.pbio.1000412
Dielenberg RA, McGregor IS (2001) Defensive behavior in rats towards predatory odors: a review. Neurosci Biobehav Rev 25:597–609. https://doi.org/10.1016/S0149-7634(01)00044-6
Rozas G, Labandeira García JL (1997) Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res 749:188–199. https://doi.org/10.1016/S0006-8993(96)01162-6
Carter RJ, Morton JA, Dunnett SB (2001) Motor coordination and balance in rodents. Curr Protoc Neurosci:1–14. https://doi.org/10.1002/0471142301.ns0812s15
Maurissen JPJ, Marable BR, Andrus AK, Stebbins KE (2003) Factors affecting grip strength testing. Neurotoxicol Teratol 25:543–553. https://doi.org/10.1016/S0892-0362(03)00073-4
Cabe PA, Tilson HA, Mitchell CL, Dennis R (1978) A simple recording grip strength device. Pharmacol Biochem Behav 8:101–102. https://doi.org/10.1016/0091-3057(78)90131-4
Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edition. Academic Press, Elsevier.
Fried NT, Moffat C, Seifert EL, Oshinsky ML (2014) Functional mitochondrial analysis in acute brain sections from adult rats reveals mitochondrial dysfunction in a rat model of migraine. Am J Phys Cell Phys 307:1017–1030. https://doi.org/10.1152/ajpcell.00332.2013
Giguère N, Delignat-Lavaud B, Herborg F et al (2019) Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout. PLoS Genet 15:1–26. https://doi.org/10.1371/journal.pgen.1008352
Callio J, Oury TD, Chu CT (2005) Manganese superoxide dismutase protects against 6- hydroxydopamine injury in mouse brains. J Biol Chem 280:18536–18542. https://doi.org/10.1038/jid.2014.371
Xavier LL, Viola GG, Ferraz AC, da Cunha C, Deonizio JM, Netto CA, Achaval M (2005) A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Protocol 16:58–64. https://doi.org/10.1016/j.brainresprot.2005.10.002
Salvatore MF, McInnis TR, Cantu MA, Apple DM, Pruett BS (2019) Tyrosine hydroxylase inhibition in substantia nigra decreases movement frequency. Mol Neurobiol 56:2728–2740. https://doi.org/10.1007/s12035-018-1256-9
Kozina EA, Khakimova GR, Khaindrava VG et al (2014) Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. J Neurol Sci 340:198–207. https://doi.org/10.1016/j.jns.2014.03.028
Mulcahy P, O’Doherty A, Paucard A et al (2012) Development and characterisation of a novel rat model of Parkinson’s disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone. Neuroscience 203:170–179. https://doi.org/10.1016/j.neuroscience.2011.12.011
Zhang H, Zhao Y, Wang Z (2015) Chronic corticosterone exposure reduces hippocampal astrocyte structural plasticity and induces hippocampal atrophy in mice. Neurosci Lett 592:76–81. https://doi.org/10.1016/j.neulet.2015.03.006
Agnihotri SK, Sun L, Yee BK, Shen R, Akundi RS, Zhi L, Duncan MJ, Cass WA et al (2019) PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice. Behav Brain Res 363:161–172. https://doi.org/10.1016/j.bbr.2019.02.006
Deng H, Le W, Shahed J et al (2008) Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families. Neurosci Lett 430:18–22. https://doi.org/10.1016/j.neulet.2007.10.018
Pfau ML, Russo SJ (2015) Peripheral and central mechanisms of stress resilience. Neurobiol Stress 1:66–79. https://doi.org/10.1016/j.ynstr.2014.09.004
Lupien SJ, De Leon M, De Santi S et al (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1:69–73. https://doi.org/10.1038/271
Lara VP, Caramelli P, Teixeira AL et al (2013) High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia. Clin Chim Acta 423:18–22. https://doi.org/10.1016/j.cca.2013.04.013
Hartmann A, Veldhuis JD, Deuschle M et al (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 18:285–289. https://doi.org/10.1016/S0197-4580(97)80309-0
Bellomo G, Santambrogio L, Fiacconi M, Scarponi AM, Ciuffetti G (1991) Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson’s disease. J Neurol 238:19–22. https://doi.org/10.1007/BF00319704
Djamshidian A, O’Sullivan SS, Papadopoulos A et al (2011) Salivary cortisol levels in Parkinson’s disease and its correlation to risk behaviour. J Neurol Neurosurg Psychiatry 82:1107–1111. https://doi.org/10.1136/jnnp.2011.245746
Volpi R, Caffarra P, Boni S et al (1997) ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. Neuropsychobiology 35:73–78. https://doi.org/10.1159/000119394
Hoyer S (1982) The young-adult and normally aged brain. Its blood flow and oxidative metabolism. A review—part I. Geriatr Arch Gerontol 1:101–116. https://doi.org/10.1016/0167-4943(82)90021-8
Kayser E, Sedensky MM, Morgan PG (2016) Region-specific defects of respiratory capacities in the Ndufs4 (KO) mouse brain. PLoS One 4:1–18. https://doi.org/10.1371/journal.pone.0148219
Yin F, Sancheti H, Patil I, Cadenas E (2017) Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radic Biol Med 100:108–122. https://doi.org/10.1016/j.freeradbiomed.2016.04.200.Energy
Lee J-K, Tran T, Tansey MG (2009) Neuroinflammation and Parkinson’s disease. J NeuroImmune Pharmacol 4:419–429. https://doi.org/10.1007/978-1-4614-5836-4_6
Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA (2016) The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry 6:1–10. https://doi.org/10.1038/tp.2016.214
Sharma N, Rao SP, Kalivendi SV et al (2019) The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: role of oxidative stress mediated downregulation of DJ-1 in Parkinson’s disease. Free Radic Biol Med 135:28–37. https://doi.org/10.1016/j.freeradbiomed.2019.02.014
Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM et al (2008) Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis 29:505–514. https://doi.org/10.1016/j.nbd.2007.11.011
Wolf RC, Vasic N, Schönfeldt-Lecuona C et al (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington’s disease: evidence from event-related fMRI. Brain 130:2845–2857. https://doi.org/10.1093/brain/awm210
McEwen BS, Nasca C, Gray JD (2016) Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology 41:3–23. https://doi.org/10.1038/npp.2015.171
Dagda RK, Cherra SJ, Kulich SM et al (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284:13843–13855. https://doi.org/10.1074/jbc.M808515200
Lakshminarasimhan H, Chattarji S (2012) Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PLoS One 7:1–6. https://doi.org/10.1371/journal.pone.0030481
Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA (2010) What causes the death of dopaminergic neurons in Parkinson’s disease? Prog Brain Res 183:59–77. https://doi.org/10.1016/S0079-6123(10)83004-3
Heeman B, Van Den Haute C, Aelvoet S et al (2011) Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J Cell Sci 124:1115–1125. https://doi.org/10.1242/jcs.078303
Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS et al (2009) PINK1-associated Parkinson’s disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33:627–638. https://doi.org/10.1016/j.molcel.2009.02.013
Maggioli E, Mcarthur S, Mauro C et al (2016) Estrogen protects the blood–brain barrier from inflammation-induced disruption and increased lymphocyte trafficking. Brain Behav Immun 51:212–222. https://doi.org/10.1016/j.bbi.2015.08.020
Acknowledgments
We thank Drs. Robert Renden, Ángel G. Diaz-Sanchez, and Gilberto Mercado Mercado for their valuable technical support and constructive criticisms.
Funding
This study was funded by the Pennington Foundation (Nevada), by National Institutes of Health (NIH) grant R01 NS105783, and by Consejo Nacional de Ciencia y Tecnología (CONACYT) 254483, 2833, and MG-fellowship by CONACYT.
Author information
Authors and Affiliations
Contributions
GM performed the experiments. GM, DRK, MMA and DRY designed the study. DRY provided technical assistance. GM, DRK and MMA analyzed the data and wrote the paper. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Ethical Approval and Consent to Participate
All animal experiments were performed according the ARRIVE guidelines and by using an animal protocol (#572) that was approved by the IACUC at the University of Nevada, Reno, USA.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
7-month PINK1-KO rats show sever motor disfunction (a) grip strength of hindlimbs, (b) number of hindlimbs slips in the 2 cm beam balance, n = 8 WT rats and 15 PINK1-KO rats. Data are mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, unpaired t-test. (PNG 113 kb)
Rights and permissions
About this article
Cite this article
Grigoruţă, M., Martínez-Martínez, A., Dagda, R.Y. et al. Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model. Mol Neurobiol 57, 1781–1798 (2020). https://doi.org/10.1007/s12035-019-01838-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-019-01838-9